Verition Fund Management’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.54M | Buy |
89,888
+16,148
| +22% | +$276K | 0.01% | 1596 |
|
|
2025
Q1 | $4.71M | Buy |
73,740
+68,424
| +1,287% | +$4.37M | 0.02% | 785 |
|
|
2024
Q4 | $646K | Buy |
5,316
+1,830
| +52% | +$223K | ﹤0.01% | 1746 |
|
|
2024
Q3 | $435K | Sell |
3,486
-8,475
| -71% | -$1.06M | ﹤0.01% | 1759 |
|
|
2024
Q2 | $1.89M | Buy |
11,961
+6,531
| +120% | +$1.03M | 0.01% | 898 |
|
|
2024
Q1 | $703K | Buy |
5,430
+1,896
| +54% | +$245K | ﹤0.01% | 1304 |
|
|
2023
Q4 | $341K | Buy |
3,534
+698
| +25% | +$67.3K | ﹤0.01% | 1327 |
|
|
2023
Q3 | $344K | Sell |
2,836
-36,200
| -93% | -$4.39M | ﹤0.01% | 1352 |
|
|
2023
Q2 | $4.47M | Buy |
39,036
+32,976
| +544% | +$3.78M | 0.06% | 355 |
|
|
2023
Q1 | $835K | Sell |
6,060
-1,543
| -20% | -$213K | 0.01% | 930 |
|
|
2022
Q4 | $985K | Buy |
7,603
+3,346
| +79% | +$434K | 0.02% | 769 |
|
|
2022
Q3 | $471K | Buy |
+4,257
| New | +$471K | 0.01% | 1527 |
|
|
2021
Q3 | – | Sell |
-4,565
| Closed | -$355K | – | 2015 |
|
|
2021
Q2 | $355K | Sell |
4,565
-7
| -0.2% | -$544 | ﹤0.01% | 1134 |
|
|
2021
Q1 | $341K | Buy |
+4,572
| New | +$341K | ﹤0.01% | 944 |
|
|
2020
Q4 | – | Sell |
-3,476
| Closed | -$488K | – | 1261 |
|
|
2020
Q3 | $488K | Buy |
+3,476
| New | +$488K | 0.01% | 516 |
|
|
2020
Q1 | – | Sell |
-5,779
| Closed | -$746K | – | 910 |
|
|
2019
Q4 | $746K | Buy |
+5,779
| New | +$746K | 0.01% | 442 |
|
|
2019
Q2 | – | Sell |
-7,482
| Closed | -$892K | – | 1233 |
|
|
2019
Q1 | $892K | Buy |
+7,482
| New | +$892K | 0.03% | 388 |
|
|
2018
Q4 | – | Sell |
-6,646
| Closed | -$1.07M | – | 1137 |
|
|
2018
Q3 | $1.07M | Buy |
6,646
+3,506
| +112% | +$566K | 0.04% | 505 |
|
|
2018
Q2 | $415K | Buy |
+3,140
| New | +$415K | 0.03% | 693 |
|